About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Fecal Biomarker Study for Patients With Ulcerative Colitis

NCT00780507·61 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Warner Chilcott

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Be willing and able to provide written informed consent for this biomarker study;
Be enrolled in Study 2007021 (QDIEM).

The record

StatusCompleted

PhaseNo phase

Taking part89

StartedAug 2007

UpdatedMay 31, 2013

Conditions

Ulcerative Colitis

Where61

Research Facility
Lowell, Arkansas, United States
Research Facility
Anaheim, California, United States
Research Facility
Folsom, California, United States

Clareo Health | Fecal Biomarker Study for Patients With Ulcerative Colitis